Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

Go back to Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

Boston Scientific (BSX) jumps as Q4 results exceed analyst expectations

January 31, 2024 6:39 AM EST

Boston Scientific (NYSE: BSX) reported stronger-than-expected results for its fourth quarter, sending its shares 4.3% higher in early New York trading Wednesday.

The company posted adjusted earnings per share (EPS) for the fourth quarter of 55 cents compared to 45 cents year-over-year (YoY), and beating the consensus estimate of 51... More

Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance

January 31, 2024 6:32 AM EST

Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.55, $0.04 better than the analyst estimate of $0.51. Revenue for the quarter came in at $3.73 billion versus the consensus estimate of $3.6 billion.

The company estimates net sales growth for the full year 2024, versus the prior year period, to be in a range of... More